CausalSentinel

Protein Dossier — APOF (Apolipoprotein F)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Height -0.143 0.0184 6.36e-15 Wald ratio 1 cis NA
Forced vital capacity (FVC) -0.0656 0.0122 8.33e-08 Wald ratio 1 cis NA
Myocardial infarction 0.295 0.071 3.28e-05 Wald ratio 1 cis NA
Coronary heart disease 0.251 0.0611 3.94e-05 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) -0.0504 0.0129 9.55e-05 Wald ratio 1 cis NA
Autism 0.528 0.194 0.00656 Wald ratio 1 cis NA
Weight -0.0354 0.0132 0.00712 Wald ratio 1 cis NA
Diagnoses - main ICD10: S76 Injury of muscle and tendon at hip and thigh level 0.881 0.334 0.00832 Wald ratio 1 cis NA
Non-cancer illness code self-reported: enlarged prostate 0.23 0.103 0.0253 Wald ratio 1 cis NA
Serum creatinine (eGFRcrea) 0.0125 0.00561 0.0263 Wald ratio 1 cis NA
Non-cancer illness code self-reported: psoriasis -0.748 0.339 0.0272 Wald ratio 1 cis NA
HOMA-B -0.0467 0.0218 0.0321 Wald ratio 1 cis NA
…and 75 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

No GWAS Catalog associations mapped to this gene.

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 189 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
psoriasis 0.268 common-variant locus MR: beta=-0.748, p=0.0272 (cis)
psoriasis vulgaris 0.155 common-variant locus no MR -> candidate analysis
skin disorder 0.116 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.089 common-variant locus no MR -> candidate analysis
coronary artery disorder 0.083 common-variant locus no MR -> candidate analysis

Of the 5 rows above, 4 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=0.11, LOEUF=2.61 — LoF-tolerant
GWAS Catalog 54 unique SNPs / 108 rows
ClinVar 55 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance